| Title |
Coenzyme q10 liquid supplementation in dyslipidemic subjects with statin-related clinical symptoms: a double-blind, randomized, placebo-controlled study
|
|---|---|
| Published in |
Drug Design, Development and Therapy, October 2019
|
| DOI | 10.2147/dddt.s223153 |
| Pubmed ID | |
| Authors |
Giuseppe Derosa, Angela D'Angelo, Pamela Maffioli |
X Demographics
The data shown below were collected from the profiles of 21 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 33% |
| Canada | 3 | 14% |
| United Kingdom | 1 | 5% |
| South Africa | 1 | 5% |
| Brazil | 1 | 5% |
| Spain | 1 | 5% |
| Unknown | 7 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 48% |
| Practitioners (doctors, other healthcare professionals) | 8 | 38% |
| Scientists | 3 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 49 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 8 | 16% |
| Researcher | 6 | 12% |
| Student > Master | 4 | 8% |
| Other | 3 | 6% |
| Lecturer | 2 | 4% |
| Other | 6 | 12% |
| Unknown | 20 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Nursing and Health Professions | 7 | 14% |
| Medicine and Dentistry | 7 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 8% |
| Biochemistry, Genetics and Molecular Biology | 3 | 6% |
| Agricultural and Biological Sciences | 3 | 6% |
| Other | 4 | 8% |
| Unknown | 21 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2021.
All research outputs
#1,700,669
of 25,387,668 outputs
Outputs from Drug Design, Development and Therapy
#74
of 2,268 outputs
Outputs of similar age
#36,230
of 362,793 outputs
Outputs of similar age from Drug Design, Development and Therapy
#3
of 29 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,793 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.